Tao Wang, PhD

Associate Professor, Biostatistics

Locations

Biostatistics

Contact Information

Education

PhD, North Carolina State University, Raleigh, NC, 2001
PhD, Southeast University, Nanjing, 1993
MS, Southeast University, Nanjing, 1990
BS, Peking University, Beijing, P.R.China, 1983

Biography

Dr Wang's expertise is in biostatistics with his methodological research focusing on statistical genetics including genetic modeling of quantitative trait loci (QTL) and genetic markers, partition of genetic variance components for quantitative traits, haplotype analysis of SNPs, and mixed models for adjustment of population structure and familial relatedness in genetic association studies. His collaborative work includes the analysis of medical or physiological data (diabetes, hypertension, etc.), genomic data (SNPs, haplotypes, methylation, proteomic data, etc.), and survival analysis for Bone Marrow Transplantation outcomes. Currently, he is serving as a statistical director in both Immunobiology working committee (IBWC) and Graft-versus-host disease (GVHD) working committee for the Center for International Blood and Marrow Transplant Research (CIBMTR).

Research Experience

Biostatistics, Statistical Genetics

Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation.

(Ballen K, Wang T, He N, Knight JM, Hong S, Frangoul H, Verdonck LF, Steinberg A, Diaz MA, LeMaistre CF, Badawy SM, Pu JJ, Hashem H, Savani B, Sharma A, Lazarus HM, Abid MB, Tay J, Rangarajan HG, Kindwall-Keller T, Freytes CO, Beitinjaneh A, Winestone LE, Gergis U, Farhadfar N, Bhatt NS, Schears RM, Gómez-Almaguer D, Aljurf M, Agrawal V, Kuwatsuka Y, Seo S, Marks DI, Lehmann L, Wood WA, Hashmi S, Saber W.) Transplant Cell Ther. 2024 Oct;30(10):1027.e1-1027.e14 PMID: 39033978 SCOPUS ID: 2-s2.0-85200332491 07/22/2024
Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis.

(Farhadfar N, Rashid N, Chen K, DeVos J, Wang T, Ballen K, Beitinjaneh A, Bhatt VR, Hamilton BK, Hematti P, Gadalla SM, Solomon SR, El Jurdi N, Lee CJ, MacMillan ML, Rangarajan HG, Schoemans H, Sharma A, Spellman SR, Wingard JR, Lee SJ.) Blood Adv. 2024 Sep 24;8(18):4963-4976 PMID: 38776400 PMCID: PMC11496972 SCOPUS ID: 2-s2.0-85204998500 05/22/2024
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations.

(Mehta RS, Petersdorf EW, Wang T, Lee SJ.) Transplant Cell Ther. 2024 Sep;30(9):909.e1-909.e11 PMID: 38992469 SCOPUS ID: 2-s2.0-85199460457 07/12/2024
The health risk of social disadvantage is transplantable into a new host.

(Turcotte LM, Wang T, Beyer KM, Cole SW, Spellman SR, Allbee-Johnson M, Williams E, Zhou Y, Verneris MR, Rizzo JD, Knight JM.) Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2404108121 PMID: 39008669 PMCID: PMC11287259 SCOPUS ID: 2-s2.0-85199015473 07/15/2024
Clinical Outcomes and Treatment Patterns in Adults With FLT3-ITDmut+ Acute Myeloid Leukemia Undergoing Allogeneic Hemopoietic Cell Transplantation in the United States and Canada.

(Pandya BJ, Burns LJ, Wang T, Xie B, Touya M, Spalding J, Block A, Kuperman G, Young C.) Transplant Cell Ther. 2024 Jul;30(7):683.e1-683.e13 PMID: 38663769 SCOPUS ID: 2-s2.0-85194953690 04/26/2024
Corrigendum to Endpoint selection and evaluation in hematology studies [Best Pract Res Clin Haematol 36 (2023) 101479].

(Brazauskas R, Eapen M, Wang T.) Best Pract Res Clin Haematol. 2024 Mar;37(1):101540 PMID: 38490768 SCOPUS ID: 2-s2.0-85185562266 03/16/2024
Using a centered general linear model for detection of interactions among biomarkers.

(Wang T, Lin CW.) Stat Methods Med Res. 2024 Mar;33(3):414-432 PMID: 38320800 SCOPUS ID: 2-s2.0-85184390679 02/07/2024
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML.

(Fein JA, Shouval R, Krieger E, Spellman SR, Wang T, Baldauf H, Fleischhauer K, Kröger N, Horowitz M, Maiers M, Miller JS, Mohty M, Nagler A, Weisdorf D, Malmberg KJ, Toor AA, Schetelig J, Romee R, Koreth J.) Blood Adv. 2024 Feb 13;8(3):581-590 PMID: 38052043 PMCID: PMC10837477 SCOPUS ID: 2-s2.0-85185534011 12/06/2023
Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation.

(Webster AP, Ecker S, Moghul I, Liu X, Dhami P, Marzi S, Paul DS, Kuxhausen M, Lee SJ, Spellman SR, Wang T, Feber A, Rakyan V, Peggs KS, Beck S.) Front Genet. 2024;15:1242636 PMID: 38633407 PMCID: PMC11021570 04/18/2024
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.

(Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Badawy SM, Bhatt N, Bhatt VR, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Hashmi S, Hematti P, Hossain NM, Inamoto Y, Lekakis LJ, Sharma A, Solomon S, Lee SJ, Couriel DR.) Transplant Cell Ther. 2024 Jan;30(1):97.e1-97.e14 PMID: 37844687 PMCID: PMC10842798 SCOPUS ID: 2-s2.0-85176587436 10/17/2023
JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.

(Rafati M, Brown DW, Zhou W, Jones K, Luo W, St Martin A, Wang Y, He M, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Bolon YT, Chanock SJ, Machiela MJ, Saber W, Gadalla SM.) Blood Adv. 2023 Dec 26;7(24):7506-7515 PMID: 38011490 PMCID: PMC10758737 SCOPUS ID: 2-s2.0-85181717421 11/27/2023
Endpoint selection and evaluation in hematology studies.

(Brazauskas R, Eapen M, Wang T.) Best Pract Res Clin Haematol. 2023 Sep;36(3):101479 PMID: 37611997 PMCID: PMC10979628 SCOPUS ID: 2-s2.0-85161313534 08/24/2023